Editorial comment on Prostate‐specific antigen follow‐up and management for patients undergoing holmium laser enucleation of the prostate
International Journal of Urology · 2024
DOI: 10.1111/iju.15334 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Urology, 2024. Verfasst von Takanori Sekito und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. Hauptthemen laut MEDLINE: Lasers, Solid-State, Transurethral Resection of Prostate, Prostatic Hyperplasia, Laser Therapy. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
ORCID-Profile: Takanori Sekito, Takuya Sadahira
Zitieren
APA
Sekito, T., & Sadahira, T. (2024). Editorial comment on Prostate‐specific antigen follow‐up and management for patients undergoing holmium laser enucleation of the prostate. International Journal of Urology. https://doi.org/10.1111/iju.15334
Vancouver
Sekito T, Sadahira T. Editorial comment on Prostate‐specific antigen follow‐up and management for patients undergoing holmium laser enucleation of the prostate. International Journal of Urology. 2024. doi:10.1111/iju.15334
BibTeX
@article{Sekito2024,
author = {Sekito, Takanori and Sadahira, Takuya},
title = {Editorial comment on Prostate‐specific antigen follow‐up and management for patients undergoing holmium laser enucleation of the prostate},
journal = {International Journal of Urology},
year = {2024},
doi = {10.1111/iju.15334}
}
EUVIMED